The Scripps Research Institute
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, The Scripps Research Institute sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).
The Scripps Research Institute: 16 sponsored US clinical trials, none currently recruiting.
The Scripps Research Institute sponsors 16 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 16 completed. 2 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcoholism, with 2 trials.
Top-decile sponsor footprint
The Scripps Research Institute ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
16 of 16 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
16 total, page 1 of 1
Medication Development in Alcoholism: Suvorexant Versus Placebo
NCT04229095
Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo
NCT04466215
Medication Development in Alcoholism: Apremilast Versus Placebo
NCT03175549
Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence
NCT02210195
Mifepristone Treatment of Alcohol Use Disorder
NCT02179749
Medication Development in Alcoholism: Investigating PPAR Agonists
NCT02158273
Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists
NCT01548417
Treatment for Cannabis Withdrawal and Dependence
NCT01611948
Gabapentin Treatment of Cannabis Dependence
NCT00974376
Duloxetine Versus Pregabalin for Alcohol Dependence
NCT00929344
Clinical and Neurobiological Effects of Cannabis Dependence in Young Adults
NCT00656487
Medication Development in Alcoholism: Acamprosate Versus Naltrexone
NCT00656630
Gabapentin Treatment of Cannabis Dependence
NCT00395044
Gabapentin Treatment of Alcohol Dependence
NCT00391716
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
NCT00000437
Naltrexone Maintenance Treatment of Alcoholism
NCT00000450
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 14 |
| Phase 4 | 2 |
Therapeutic Areas
How the The Scripps Research Institute early-phase archive is shaped
16 indexed studies, none listed as recruiting (0% open); 16 completed (100%).
Phase mix: 2 late (III/IV) vs 14 early (I/II) (early-phase heavy).
Top condition: Alcoholism (2 trials), 5 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
The Scripps Research Institute: archived-pipeline peers nationwide
Peers matched on 16 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
The Scripps Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 16 archived trials
- Accelerated Community Oncology Research Network · 16 trials · 0% recruiting
- Altimmune · 16 trials · 6% recruiting
- American University · 16 trials · 13% recruiting
- Anthera Pharmaceuticals · 16 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this The Scripps Research Institute page
16 registered trials is a research-attention snapshot, not an endorsement of The Scripps Research Institute or any single study.
- None of The Scripps Research Institute's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Alcoholism is the condition The Scripps Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcoholism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The Scripps Research Institute pipeline card: 16 registered trials from official public datasets.Report a data error.